Kelly Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,644
Closed -$102K 567
2024
Q2
$102K Buy
3,644
+343
+10% +$9.44K 0.04% 151
2024
Q1
$91.6K Buy
3,301
+200
+6% +$5.55K 0.04% 157
2023
Q4
$89.3K Buy
3,101
+35
+1% +$1.06K 0.04% 152
2023
Q3
$102K Sell
3,066
-108
-3% -$3.82K 0.05% 123
2023
Q2
$116K Sell
3,174
-359
-10% -$14K 0.06% 113
2023
Q1
$144K Sell
3,533
-224
-6% -$9.68K 0.07% 93
2022
Q4
$192K Buy
3,757
+690
+22% +$33.1K 0.1% 86
2022
Q3
$134K Buy
3,067
+19
+0.6% +$923 0.08% 94
2022
Q2
$160K Buy
3,048
+17
+0.6% +$866 0.08% 89
2022
Q1
$157K Sell
3,031
-388
-11% -$20.1K 0.07% 96
2021
Q4
$202K Sell
3,419
-481
-12% -$23.8K 0.09% 78
2021
Q3
$168K Sell
3,900
-123,269
-97% -$5.46M 0.09% 74
2021
Q2
$3.25M Buy
127,169
+124,081
+4,018% +$4.83M 0.13% 52
2021
Q1
$112K Sell
3,088
-305
-9% -$10.8K 0.07% 78
2020
Q4
$125K Buy
3,393
+286
+9% +$10.5K 0.09% 58
2020
Q3
$108K Buy
3,107
+368
+13% +$12.9K 0.08% 51
2020
Q2
$85K Sell
2,739
-18
-0.7% -$612 0.07% 58
2020
Q1
$85.4K Buy
2,757
+149
+6% +$5.08K 0.11% 49
2019
Q4
$96.9K Sell
2,608
-324
-11% -$11.5K 0.07% 51
2019
Q3
$100K Buy
2,932
+273
+10% +$9.93K 0.09% 48
2019
Q2
$109K Buy
2,659
+18
+0.7% +$715 0.1% 43
2019
Q1
$106K Buy
+2,641
New +$106K 0.12% 41

Other funds holding PFE

Kelly Financial Services's PFE Position: Q3 2024 in Review

Kelly Financial Services sold out of Pfizer (PFE) in Q3 2024, closing a stake of 3,644 shares — an estimated $102K sold.

Kelly Financial Services first reported a position in PFE in Q1 2019 and held it in 22 quarters. The position peaked at $3.25M in Q2 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Kelly Financial Services reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 3,644 Pfizer shares in Q3 2024, an estimated $102K.
  • Kelly Financial Services first reported a position in Pfizer in Q1 2019 and held it in 22 quarters.
  • Kelly Financial Services's Pfizer position peaked at $3.25M in Q2 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.